Abstract
Antiviral drugs are a proposed medical intervention to reduce household transmission of influenza viruses. In a previously described randomised, placebo-controlled trial in Dhaka, Bangladesh, we showed that oseltamivir treatment of index patients was able to reduce influenza symptom duration and virus shedding. In a further analysis that is part of the same study, we aimed to assess efficacy of oseltamivir to reduce secondary household illnesses in the same cohort. In this double-blind oseltamivir efficacy trial, we identified index patients aged older than 1 year through surveillance of households in Dhaka, Bangladesh. We randomly allocated eligible patients (1:1) to receive oseltamivir or placebo twice-daily for 5 days, and we stratified them by enrolment 48 h versus 48-120 h since illness onset. Participants provided nasal wash specimens at enrolment and 2, 4, and 7 days after enrolment and were visited daily by a research assistant to record symptoms, both in index patients and in household members. For this part of the study, household members were asked to give respiratory specimens for influenza PCR testing. Our primary outcomes were household secondary illness and PCR-confirmed influenza virus infection, assessed in hou...Continue Reading
References
Sep 26, 1997·The New England Journal of Medicine·F G HaydenK Wightman
Jul 15, 1999·JAMA : the Journal of the American Medical Association·A S MontoA Crisp
Oct 28, 1999·The New England Journal of Medicine·F G HaydenR G Mills
Jun 24, 2000·Lancet·K G NicholsonP Ward
Oct 4, 2000·JAMA : the Journal of the American Medical Association·E S HurwitzN J Cox
Feb 15, 2001·JAMA : the Journal of the American Medical Association·R WelliverUNKNOWN Oseltamivir Post Exposure Prophylaxis Investigator Group
Feb 27, 2001·The Pediatric Infectious Disease Journal·R J WhitleyP Ward
Apr 28, 2006·Nature·Neil M FergusonDonald S Burke
Feb 26, 2009·Emerging Infectious Diseases·David S Fedson
Jan 1, 2010·The New England Journal of Medicine·Simon CauchemezNeil M Ferguson
Feb 4, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sophia NgGabriel M Leung
Nov 26, 2013·The Lancet Infectious Diseases·Alicia M FryW Abdullah Brooks
Citations
Nov 28, 2015·Trends in Microbiology·Tim K TsangBenjamin J Cowling
Mar 20, 2015·The Lancet Infectious Diseases·Ian G Barr, Heath A Kelly
Jan 18, 2018·Influenza and Other Respiratory Viruses·Hao-Yuan ChengWan-Ting Huang
Sep 19, 2018·Emerging Infectious Diseases·Aubree GordonEva Harris
Jul 11, 2018·Influenza and Other Respiratory Viruses·Nobuo HirotsuTakahiro Hasegawa
Apr 16, 2020·PLoS Pathogens·Leo Yi Yang LeeWendy S Barclay
Dec 20, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy M UyekiAndrew T Pavia
Sep 22, 2017·The Journal of Infectious Diseases·Fiona P HaversAlicia M Fry
Apr 30, 2020·BMC Public Health·Shinya Tsuzuki, Keisuke Yoshihara
Jul 15, 2020·Open Forum Infectious Diseases·Joshua T SchifferLawrence Corey
Jul 28, 2020·The Journal of Infectious Diseases·Alpana WaghmareJoshua T Schiffer
Nov 25, 2020·Trials·Kira L NewmanUNKNOWN Seattle Flu Study Investigators
Oct 27, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Takuji KomedaHiroshi Mukae
Jan 13, 2021·Wilderness & Environmental Medicine·Yoshihiro AokiNaoto Mizushiro
May 8, 2021·ClinicoEconomics and Outcomes Research : CEOR·Christopher WallickDalia Moawad
Jul 11, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Frederick G HaydenArnold S Monto